Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr Reddy’s Accelerates Vaccine Efforts

Pfizer CEO Offers Vaccine Update; Cipla Launches Antibody Test

Executive Summary

Dr Reddy’s is collaborating with the Indian government’s biotechnology department to conduct Sputnik V vaccine clinical trials In India, after it received approval from the DCGI. Pfizer’s CEO has offered an update on the development and distribution of the COVID-19 vaccine that it is developing in partnership with BioNTech. Cipla has launched COVID-19 antibody detection kits for India. And the WHO has called for management of the coronavirus “infodemic.”

You may also be interested in...

Alvogen Companies Donate To Support COVID Vaccines

Alvogen and sister company Alvotech have donated to UNICEF to support vaccine supply to over 90 low-and-middle-income countries, while Hikma has also made a multi-million-dollar donation. India’s Dr Reddy’s is moving ahead with the Sputnik V vaccine, while AstraZeneca is partnering with Insud Pharma on its vaccine in Spain. Meanwhile, the UK government has extended its vaccination contract with Wockhardt.

Aurobindo Announces Vaccine Partnership For India

Aurobindo has partnered with US based Covaxx for the first-ever peptide-based COVID-19 vaccine for the Indian market. While Dr Reddy’s has filed for favipiravir in Canada, Cipla has launched its second antigen detection test kit in India. And the Serum Institute of India will be providing Bangladesh with Oxford-AstraZeneca vaccine doses via Beximco

Kelix Strikes A Deal To Acquire 14 Oncology Injectables

Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts